668 related articles for article (PubMed ID: 30018088)
1. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.
Masson L; Arnold KB; Little F; Mlisana K; Lewis DA; Mkhize N; Gamieldien H; Ngcapu S; Johnson L; Lauffenburger DA; Abdool Karim Q; Abdool Karim SS; Passmore JA
Sex Transm Infect; 2016 May; 92(3):186-93. PubMed ID: 26511781
[TBL] [Abstract][Full Text] [Related]
3. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
4. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
Garrett N; Mtshali A; Osman F; Masson L; McKinnon LR; Singh R; Mitchev N; Ngobese H; Kharsany ABM; Abdool Karim S; Mlisana K; Passmore JA; Rompalo A; Mindel A; Liebenberg L
Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480
[TBL] [Abstract][Full Text] [Related]
5. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
[TBL] [Abstract][Full Text] [Related]
6. Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT).
Ramboarina S; Crucitti T; Gill K; Bekker LG; Harding-Esch EM; van de Wijgert JHHM; Huynh BT; Fortas C; Harimanana A; Mayouya Gamana T; Randremanana RV; Mangahasimbola R; Dziva Chikwari C; Kranzer K; Mackworth-Young CRS; Bernays S; Thomas N; Anderson D; Tanko FR; Manhanzva M; Lurie M; Khumalo F; Sinanovic E; Honda A; Pidwell T; Francis SC; Masson L; Passmore JA;
BMJ Open; 2024 May; 14(5):e084918. PubMed ID: 38692732
[TBL] [Abstract][Full Text] [Related]
7. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
8. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
[TBL] [Abstract][Full Text] [Related]
9. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.
Mngomezulu K; Mzobe GF; Mtshali A; Osman F; Liebenberg LJP; Garrett N; Singh R; Rompalo A; Mindel A; Karim SSA; Karim QA; Baxter C; Ngcapu S
Front Immunol; 2021; 12():695201. PubMed ID: 34177961
[TBL] [Abstract][Full Text] [Related]
10. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
11. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
[TBL] [Abstract][Full Text] [Related]
12. Analysis of bacterial vaginosis, the vaginal microbiome, and sexually transmitted infections following the provision of menstrual cups in Kenyan schools: Results of a nested study within a cluster randomized controlled trial.
Mehta SD; Zulaika G; Agingu W; Nyothach E; Bhaumik R; Green SJ; van Eijk AM; Kwaro D; Otieno F; Phillips-Howard P
PLoS Med; 2023 Jul; 20(7):e1004258. PubMed ID: 37490459
[TBL] [Abstract][Full Text] [Related]
13. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
14. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
15. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
[TBL] [Abstract][Full Text] [Related]
16. Vaginal Microbiota and Mucosal Immune Markers in Women With Vulvovaginal Discomfort.
Mitchell CM; Watson L; Mitchell AJ; Hyrien O; Bergerat A; Valint DJ; Pascale A; Hoffman N; Srinivasan S; Fredricks DN
Sex Transm Dis; 2020 Apr; 47(4):269-274. PubMed ID: 32044865
[TBL] [Abstract][Full Text] [Related]
17. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
Doerflinger SY; Throop AL; Herbst-Kralovetz MM
J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the vaginal microflora in health and disease.
Datcu R
Dan Med J; 2014 Apr; 61(4):B4830. PubMed ID: 24814599
[TBL] [Abstract][Full Text] [Related]
19. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
Alcaide ML; Rodriguez VJ; Brown MR; Pallikkuth S; Arheart K; Martinez O; Roach M; Fichorova RN; Jones DL; Pahwa S; Fischl MA
AIDS Res Hum Retroviruses; 2017 Apr; 33(4):309-317. PubMed ID: 27897054
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of a commercial multiplex PCR for the diagnosis of bacterial vaginosis.
van der Veer C; van Houdt R; van Dam A; de Vries H; Bruisten S
J Med Microbiol; 2018 Sep; 67(9):1265-1270. PubMed ID: 29985123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
